U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    Igfbp7 insulin-like growth factor binding protein 7 [ Mus musculus (house mouse) ]

    Gene ID: 29817, updated on 6-Oct-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    IGFBP7 promotes endothelial cell repair in the recovery phase of acute lung injury.

    IGFBP7 promotes endothelial cell repair in the recovery phase of acute lung injury.
    He R, Feng B, Zhang Y, Li Y, Wang D, Yu L., Free PMC Article

    06/30/2024
    Structural insight into CD93 recognition by IGFBP7.

    Structural insight into CD93 recognition by IGFBP7.
    Xu Y, Sun Y, Zhu Y, Song G.

    03/14/2024
    METTL3-mediated m[6]A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1/DNMT3a-IGFBP7 axis.

    METTL3-mediated m(6)A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1/DNMT3a-IGFBP7 axis.
    Tang Y, Hong F, Ding S, Yang J, Zhang M, Ma Y, Zheng Q, Yang D, Jin Y, Ma C.

    10/12/2023
    Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation.

    Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation.
    Yu JT, Hu XW, Yang Q, Shan RR, Zhang Y, Dong ZH, Li HD, Wang JN, Li C, Xie SS, Dong YH, Ni WJ, Jiang L, Liu XQ, Wei B, Wen JG, Liu MM, Chen Q, Yang YR, Zhang GY, Zang HM, Jin J, Wu YG, Zhong X, Li J, Wang W, Meng XM.

    10/1/2022
    IGFBP7 aggravates sepsis-induced acute lung injury by activating the ERK1/2 pathway.

    IGFBP7 aggravates sepsis-induced acute lung injury by activating the ERK1/2 pathway.
    Xu Q, Wang J.

    07/24/2021
    Insulin-like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease.

    Insulin-like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease.
    Yan H, Li T, Wang Y, Li H, Xu J, Lu X.

    08/29/2020
    The mechanism may be that eleutheroside B can activate the insulin-like growth factor (IGF) pathway and its downstream pathway by downregulating the expression of IGFBP-7, thus promoting cell proliferation. Therefore, our results suggest that eleutheroside B is a potential drug for Acute kidney injury (AKI) treatment.

    Eleutheroside B Protects against Acute Kidney Injury by Activating IGF Pathway.
    Zang H, Yang Q, Li J., Free PMC Article

    03/14/2020
    IGFBP7 inhibited receptor activation of nuclear factor-kappaB (NF-kappaB) ligand (RANKL)-induced osteoclastogenesis.

    IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C, Hou W, Chen M, Lu J, Chen E, Tang L, Hang K, Ding Q, Li Y, Zhang W, He R., Free PMC Article

    03/7/2020
    IGFBP7 has a role in regulating sepsis-induced epithelial-mesenchymal transition through ERK1/2 signaling

    IGFBP7 regulates sepsis-induced epithelial-mesenchymal transition through ERK1/2 signaling.
    Wang X, Li Y, Zhao Z, Meng Y, Bian J, Bao R, Zhu K, Yang T.

    02/15/2020
    IGFBPrP1 promoted autophagy and contributed to hepatic stellate cell activation via mutual regulation between H19 and the PI3K/AKT/mTOR pathway.

    IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
    Huang TJ, Ren JJ, Zhang QQ, Kong YY, Zhang HY, Guo XH, Fan HQ, Liu LX.

    01/18/2020
    Our findings define an immune component of the pleiotropic mechanisms through which IGFBP7 suppresses hepatocellular carcinoma

    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Akiel M, Guo C, Li X, Rajasekaran D, Mendoza RG, Robertson CL, Jariwala N, Yuan F, Subler MA, Windle J, Garcia DK, Lai Z, Chen HH, Chen Y, Giashuddin S, Fisher PB, Wang XY, Sarkar D., Free PMC Article

    09/30/2017
    Study shows that IGFBP7 contributes significantly to mesenchymal stromal cells (MSC)-mediated immune modulation, as is shown by decreasing ability of IGFBP7 knockdown in MSCs to restore proliferation and cytokine production in T-cells.

    Mesenchymal Stromal Cells Mitigate Experimental Colitis via Insulin-like Growth Factor Binding Protein 7-mediated Immunosuppression.
    Liao Y, Lei J, Liu M, Lin W, Hong D, Tuo Y, Jiang MH, Xia H, Wang M, Huang W, Xiang AP., Free PMC Article

    06/24/2017
    data suggest that IGFBP-7 was up regulated during EAE and inhibit the transition from OPCs to mature OLs, implying its use as a potential therapeutic target for the treatment of inflammatory demyelinating diseases

    Insulin-like growth factor-binding protein 7 is up-regulated during EAE and inhibits the differentiation of oligodendrocyte precursor cells.
    Tan W, Pu Y, Shao Q, Fang X, Han D, Zhao M, Cao L.

    08/22/2015
    Our data suggest that loss of Igfbp7 induces precocious involution possibly through diminished cell survival signals.

    Loss of Igfbp7 causes precocious involution in lactating mouse mammary gland.
    Chatterjee S, Bacopulos S, Yang W, Amemiya Y, Spyropoulos D, Raouf A, Seth A., Free PMC Article

    01/3/2015
    Angiomodulin is necessary for cardiac commitment of embryonic stem cells (ESCs) and its regulation depends on TAp63 isoform.

    Angiomodulin is required for cardiogenesis of embryonic stem cells and is maintained by a feedback loop network of p63 and Activin-A.
    Wolchinsky Z, Shivtiel S, Kouwenhoven EN, Putin D, Sprecher E, Zhou H, Rouleau M, Aberdam D.

    09/13/2014
    results show that Smarcb1 is required for transcriptional activation of Igfbp7 and show that re-introduction of Igfbp7 alone can hinder tumor development; results define a novel mechanism for Smarcb1-mediated tumorigenesis

    Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J, Klochendler A, Isaac S, Eden A.

    07/26/2014
    a model whereby IGFBP7 binds to unoccupied IGF1R and suppresses downstream signaling, thereby inhibiting protein synthesis, cell growth, and survival.

    IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
    Evdokimova V, Tognon CE, Benatar T, Yang W, Krutikov K, Pollak M, Sorensen PH, Seth A.

    05/25/2013
    IGFBP7 has a novel role in mouse uterus: it is regulating uterine receptivity through Th1/Th2 lymphocyte balance and decidualization.

    A novel role of IGFBP7 in mouse uterus: regulating uterine receptivity through Th1/Th2 lymphocyte balance and decidualization.
    Liu ZK, Wang RC, Han BC, Yang Y, Peng JP., Free PMC Article

    03/2/2013
    fear extinction-induced IGF2/IGFBP7 signalling promotes the survival of 17-19-day-old newborn hippocampal neurons

    A hippocampal insulin-growth factor 2 pathway regulates the extinction of fear memories.
    Agis-Balboa RC, Arcos-Diaz D, Wittnam J, Govindarajan N, Blom K, Burkhardt S, Haladyniak U, Agbemenyah HY, Zovoilis A, Salinas-Riester G, Opitz L, Sananbenesi F, Fischer A., Free PMC Article

    12/24/2011
    Results demonstrate that the vascular-specific marker angiomodulin (AGM) modulates vascular remodeling in part by temporizing the proangiogenic effects of VEGF-A.

    Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis.
    Hooper AT, Shmelkov SV, Gupta S, Milde T, Bambino K, Gillen K, Goetz M, Chavala S, Baljevic M, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, Vahdat L, Evans T, Rafii S., Free PMC Article

    03/28/2011
    study showed that IGFBP-rP1 (IGFBP7) was expressed in dysregulated podocytes in a human immunodeficiency virus-associated nephropathy model and in immature podocytes in the developing kidney; conclude that IGFBP-rP1 may be a product of injured podocytes

    Proteomic analysis identifies insulin-like growth factor-binding protein-related protein-1 as a podocyte product.
    Matsumoto T, Hess S, Kajiyama H, Sakairi T, Saleem MA, Mathieson PW, Nojima Y, Kopp JB., Free PMC Article

    10/30/2010
    inhibition of Malignant melanoma growth is due to apoptosis and reduced expression of VEGF induced by pEGFC1-IGFBP7

    Intratumoral injection of pEGFC1-IGFBP7 inhibits malignant melanoma growth in C57BL/6J mice by inducing apoptosis and down-regulating VEGF expression.
    Chen RY, Chen HX, Jian P, Xu L, Li J, Fan YM, Tu YT.

    06/28/2010
    IGFBP-7 can regulate glioma cell migration through the AKT-ERK pathway, thereby playing an important role in glioma growth and migration

    Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration.
    Jiang W, Xiang C, Cazacu S, Brodie C, Mikkelsen T., Free PMC Article

    01/21/2010
    Mac25 interacts with the extracellular matrix proteins and glycosaminoglycans that are expressed in most blood vessels including high endothelial venules, as well as with chemokines implicated in regulation of lymphocyte trafficking, e.g., SLC and IP-10.

    A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines.
    Nagakubo D, Murai T, Tanaka T, Usui T, Matsumoto M, Sekiguchi K, Miyasaka M.

    01/21/2010
    Proteolytic processing of mac25 modulates its insulin/IGF-1-dependent growth-stimulatory activity.

    Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity.
    Ahmed S, Yamamoto K, Sato Y, Ogawa T, Herrmann A, Higashi S, Miyazaki K.

    01/21/2010
    firstprevious page of 1 nextlast